Cargando…

Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity

Doxorubicin is the mainstay of treatment for various haematological malignancies and solid tumours. However, its clinical application may be hampered by dose-dependent cardiotoxicity. The mechanism of doxorubicin-induced cardiotoxicity may involve various signalling pathways including free radical g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Jun, Hu, Wei, Zhang, Da-dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2015
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594674/ https://www.ncbi.nlm.nih.gov/pubmed/26177159 http://dx.doi.org/10.1111/jcmm.12633

Ejemplares similares

Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine
por: Cheah, Irwin K., et al.
Publicado: (2023)

Cardioprotective effect of grape polyphenol extract against doxorubicin induced cardiotoxicity
por: Sergazy, Shynggys, et al.
Publicado: (2020)

Resveratrol, a polyphenol phytoalexin, protects cardiomyocytes against anoxia/reoxygenation injury via the TLR4/NF-κB signaling pathway
por: ZHANG, CUI, et al.
Publicado: (2012)

The Protective Role of Resveratrol against Arsenic Trioxide-Induced Cardiotoxicity
por: Zhang, Weiqian, et al.
Publicado: (2013)

Asiatic Acid Protects against Doxorubicin-Induced Cardiotoxicity in Mice
por: Hu, Xiaoping, et al.
Publicado: (2020)

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
por: Hole, Lisa Drange, et al.
Publicado: (2014)

Dapagliflozin May Protect Against Doxorubicin-Induced Cardiotoxicity
por: Ulusan, Sebahat, et al.
Publicado: (2023)

Levosimendan Protects against Doxorubicin-Induced Cardiotoxicity by Regulating the PTEN/Akt Pathway
por: Li, Ling-Li, et al.
Publicado: (2020)

Niosomes encapsulated in biohydrogels for tunable delivery of phytoalexin resveratrol
por: Machado, Noelia D., et al.
Publicado: (2019)

Understanding the Protective Role of Exosomes in Doxorubicin-Induced Cardiotoxicity
por: Zhang, Guoxia, et al.
Publicado: (2022)

In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity
por: Chen, Chih-Tai, et al.
Publicado: (2015)

Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
por: Sun, Jing, et al.
Publicado: (2013)

Phoenix dactylifera Protects against Doxorubicin-Induced Cardiotoxicity and Nephrotoxicity
por: Wang, Yuewen, et al.
Publicado: (2019)

The Protective Effect of Citronellol against Doxorubicin-Induced Cardiotoxicity in Rats
por: Munir, Sania, et al.
Publicado: (2023)

Chrysophanol protects against doxorubicin-induced cardiotoxicity by suppressing cellular PARylation
por: Lu, Jing, et al.
Publicado: (2019)

A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity
por: Singh, Mandeep, et al.
Publicado: (2023)

Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity
por: Shoukry, Heba Samy, et al.
Publicado: (2017)

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
por: Guo, Rui, et al.
Publicado: (2018)

Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
por: Zhang, Lili, et al.
Publicado: (2019)

The Protective Effects of Silymarin against Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity in Rats
por: Rašković, Aleksandar, et al.
Publicado: (2011)

Protective effect of Vernonia amygdalina Delile against doxorubicin-induced cardiotoxicity
por: Syahputra, R.A., et al.
Publicado: (2021)

Protective Effects of Dexrazoxane against Doxorubicin-Induced Cardiotoxicity: A Metabolomic Study
por: QuanJun, Yang, et al.
Publicado: (2017)

The Phytoalexin Resveratrol Regulates the Initiation of Hypersensitive Cell Death in Vitis Cell
por: Chang, Xiaoli, et al.
Publicado: (2011)

Correction: Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity
por: Guo, Rui, et al.
Publicado: (2019)

Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart
por: Sun, Xi-Peng, et al.
Publicado: (2017)

Shenmai Injection Protects Against Doxorubicin-Induced Cardiotoxicity via Maintaining Mitochondrial Homeostasis
por: Li, Lin, et al.
Publicado: (2020)

Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression
por: Wang, Panxia, et al.
Publicado: (2021)

Anticancer prodrugs of butyric acid and formaldehyde protect against doxorubicin-induced cardiotoxicity
por: Rephaeli, A, et al.
Publicado: (2007)

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity
por: Zhou, Peng, et al.
Publicado: (2022)

The true colors of autophagy in doxorubicin-induced cardiotoxicity
por: Xiao, Bin, et al.
Publicado: (2019)

Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats
por: Stilinović, Nebojša, et al.
Publicado: (2012)

Protective effect of nebivolol on doxorubicin-induced cardiotoxicity in rats
por: Mohamed, Enas Ahmed, et al.
Publicado: (2018)

Role of acetylation in doxorubicin-induced cardiotoxicity
por: Li, Daisong, et al.
Publicado: (2021)

A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities
por: Hu, Li-Feng, et al.
Publicado: (2021)

Harpagoside Protects Against Doxorubicin-Induced Cardiotoxicity via P53-Parkin-Mediated Mitophagy
por: Li, Weili, et al.
Publicado: (2022)

Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
por: Basal, Omnia A., et al.
Publicado: (2023)

Autophagy and mitophagy in the context of doxorubicin-induced cardiotoxicity
por: Koleini, Navid, et al.
Publicado: (2017)

Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
por: Wu, Bin Bin, et al.
Publicado: (2022)

Cardioprotective Roles of β-Hydroxybutyrate Against Doxorubicin Induced Cardiotoxicity
por: Liu, Yihai, et al.
Publicado: (2021)

Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicity
por: Xi, Lei, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_c1bfqgogbf25sde25rjmk4m66q